MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BioScrip Company Profile (NASDAQ:BIOS)

Consensus Ratings for BioScrip (NASDAQ:BIOS) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $3.00 (14.07% upside)

Analysts' Ratings History for BioScrip (NASDAQ:BIOS)
Show:
DateFirmActionRatingPrice TargetActions
3/5/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2015Dougherty & CoLower Price TargetBuy$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015SunTrust Banks Inc.DowngradeBuy -> Neutral$5.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Barrington ResearchReiterated RatingOutperform$7.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Jefferies GroupLower Price TargetBuy$8.00 -> $6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/9/2015Craig HallumInitiated CoverageBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for BioScrip (NASDAQ:BIOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/5/2016Q1($0.12)($0.17)$232.38 million$238.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2016Q4($0.08)($0.13)$238.30 million$243.75 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.10)($0.38)$229.89 million$247.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.11)($3.60)$269.38 million$262.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.04)($0.17)$259.60 million$261.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015Q414$0.01($0.69)$259.62 million$253.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314$0.02($0.42)$240.08 million$244.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214($0.02)($0.01)$233.70 million$247.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.03)($0.13)$222.65 million$239.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q413$0.02$0.02$237.58 million$243.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013$0.04$0.13$206.47 million$190.73 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q1 2013$0.02$0.04$189.36 million$199.07 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2013Q4 2012$0.01$0.04$173.87 million$180.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.01)($0.01)$159.86 million$170.36 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2012($0.01)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2012($0.01)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2012$0.09$0.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2011$0.09$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2011$0.08$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.01)$0.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2011$0.04($1.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for BioScrip (NASDAQ:BIOS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.03)($0.03)($0.03)
Q4 20163($0.01)$0.01$0.00
Q1 20171($0.08)($0.08)($0.08)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.04)($0.04)($0.04)
Q4 20171$0.00$0.00$0.00
(Data provided by Zacks Investment Research)
Dividend History for BioScrip (NASDAQ:BIOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for BioScrip (NASDAQ:BIOS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/22/2016Coliseum Capital Management, LDirectorBuy4,200,000$2.00$8,400,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2016David W GoldingDirectorBuy12,500$2.48$31,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Coliseum Capital Management, LDirectorBuy789,503$1.88$1,484,265.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Coliseum Capital Management, LDirectorBuy632,907$1.81$1,145,561.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015David W GoldingDirectorBuy20,000$1.54$30,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Richard M SmithCEOBuy5,000$4.27$21,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Yon JordenDirectorBuy5,000$3.47$17,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Myron Z HolubiakDirectorSell5,000$7.94$39,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Yon JordenDirectorBuy5,000$7.21$36,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Daniel ColucciVPSell18,500$12.40$229,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013David HubersDirectorSell11,200$12.23$136,976.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013Patricia BoguszVPSell39,687$11.94$473,862.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Kohlberg Management V, LlcInsiderSell6,895,873$13.00$89,646,349.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Myron Z HolubiakDirectorSell31,200$16.34$509,808.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2012Stuart A SamuelsDirectorSell11,200$9.66$108,192.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for BioScrip (NASDAQ:BIOS)
DateHeadline
07/01/16 02:51 PMTracking Stock Volatility for: BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
07/01/16 02:51 PMBioScrip, Inc. (NASDAQ:BIOS) Updated Price Targets - FTSE News
06/30/16 08:18 PMInvestor News: Deadline upcoming in Settlement in the Lawsuit against BioScrip Inc (NASDAQ: BIOS)
06/30/16 10:44 AMInvestor News: Deadline upcoming in Settlement in the Lawsuit against BioScrip Inc (NASDAQ: BIOS) - GroundReport
06/29/16 11:07 AMBRIEF-North Tide Capital Master reports a passive stake of 7.5 pct in Bioscrip Inc
06/28/16 03:01 PMCheck on Share Volatility: BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
06/27/16 02:29 PMInsiders Are Buying These Shares: BioScrip Inc (NASDAQ:BIOS), Farmers National Banc Corp (NASDAQ:FMNB), IDI ... - iStreetWire
06/27/16 02:29 PMStock Volatility in Review: BioScrip, Inc. (NASDAQ:BIOS) - Engelwood Daily
06/27/16 07:31 AMColiseum Capital Adds To Its Stake In BioScrip Inc (BIOS) - Insider Monkey (blog)
06/26/16 02:30 PMColiseum Capital Adds To Its Stake In BioScrip Inc (BIOS) -
06/25/16 05:58 AMTraders Are Bearish BioScrip Inc After Today's Gap Down - Engelwood Daily
06/24/16 02:50 PMNew Broker Ratings For BioScrip, Inc. (NASDAQ:BIOS) - FTSE News
06/24/16 06:34 AMBioScrip Inc. (BIOS) is Trading Lower on Unusual Volume for June 22 - Equities.com
06/24/16 06:34 AMReview of Analysts Ranking: Stryker Corporation (NYSE:SYK) , BioScrip, Inc. (NASDAQ:BIOS) - Street Updates
06/23/16 10:16 PMBioScrip : Completes Public Offering of Common Stock
06/23/16 04:23 PMBioScrip Inc (NASDAQ:BIOS) & Pluristem Therapeutics (NASDAQ:PSTI) Healthcare Trader's Round Up - Wall Street 24
06/23/16 04:23 PMForm 8-K BioScrip, Inc. For: Jun 22 - StreetInsider.com
06/23/16 04:23 PMBioScrip Inc. (BIOS) is Trading Higher on Unusual Volume for June 21 - Equities.com
06/23/16 04:23 PMBioScrip, Inc. versus Concord Medical Services Holdings Limited Head to Head Compare - CML News
06/22/16 02:49 PMBioScrip, Inc. (NASDAQ:BIOS) Upside Stock Momentum at EXTREME Strength - CML News
06/22/16 09:52 AMBIOSCRIP, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/22/16 09:29 AMBioScrip Completes Public Offering of Common Stock - [at noodls] - DENVER, June 22, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (the 'Company' or 'BioScrip') announced today that it has completed its previously announced underwritten public offering (the 'Offering') ...
06/22/16 07:36 AMBioScrip Inc. (BIOS) Jumps 8.1% on June 20 - Equities.com
06/21/16 02:46 PMMicrocap Gainers: BioScrip, Inc. (NASDAQ:BIOS), Netlist Inc. (NASDAQ:NLST), Fate Therapeutics, Inc. (NASDAQ:FATE ... - KC Register
06/21/16 07:35 AMBioScrip, Inc. (NASDAQ:BIOS): Growth Forecast - RealistInvestor.com
06/21/16 07:35 AMA Director at BioScrip Inc (NASDAQ: BIOS) is Buying Shares - Analyst Ratings
06/21/16 07:00 AMHigh-Flying BioScrip Inc. (BIOS) Registers Insider Buying; Amazon Supplier and Funeral Services Provider Also See Insiders Buy Shares -
06/20/16 02:51 PMAnalytical Approach on BioScrip Incorporated (BIOS)
06/20/16 09:15 AMHC Stocks Alerts: BioScrip Inc (NASDAQ:BIOS), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) - share market updates (press release)
06/20/16 09:15 AMAnalyst's Stocks Rating Activity: BioScrip, Inc. (NASDAQ:BIOS) , MannKind Corporation (NASDAQ:MNKD) - Street Updates
06/19/16 07:31 AMBioScrip, Inc. (NASDAQ:BIOS) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 02:43 PMBioScrip Prices Underwritten Offering of Common Stock - GlobeNewswire (press release)
06/18/16 07:32 AMBioScrip Inc. (BIOS) Jumps 19.32% on June 17 - Equities.com
06/17/16 10:47 AMBioScrip Inc (NASDAQ:BIOS) & Zimmer Biomet Holdings Inc (NYSE:ZBH) are Hot Healthcare Stocks - Wall Street 24
06/17/16 10:47 AMIs Share Dilution A Certainty For BioScrip Inc. (NASDAQ:BIOS)? - Scibility Media
06/17/16 05:05 AMBIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and -
06/16/16 10:39 PMBRIEF-BioScrip prices 40 mln shares offering at $2.00 per share - * Says offering of 40.0 million common shares priced at $2.00 per share
06/16/16 02:50 PMComplete Analysis of: Melco Crown Entertainment Limited (NASDAQ:MPEL), BioScrip, Inc. (NASDAQ:BIOS) - Beacon Chronicle
06/16/16 02:50 PMForm 8-K BioScrip, Inc. For: Jun 16 - StreetInsider.com
06/16/16 07:13 AMBioScrip Inc. (BIOS) Drops 8.33% on June 14 - Equities.com
06/16/16 07:13 AMPrice Fluctuations to Observe: BioScrip, Inc. (NASDAQ:BIOS) , Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) - Street Updates
06/16/16 07:13 AMForm DEFA14A BioScrip, Inc. - StreetInsider.com
06/16/16 06:23 AMBIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events -
06/16/16 06:08 AM7:08 am Bioscrip announces amendments to previously-announced HS Infusion acquisition; closing consideration reduced from $85 million to $75 million -
06/16/16 06:00 AMBioScrip and Home Solutions Enter Into Amended Agreement - [GlobeNewswire] - Amendment Further Enhances Value for Shareholders. Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity. DENVER and HAMMONTON, N.J., June 16, 2016-- BioScrip, Inc., ...
06/15/16 02:53 PMForm 4 BioScrip, Inc. For: Jun 10 Filed by: Coliseum Capital Partners II, LP - StreetInsider.com
06/15/16 02:53 PMStock's Earnings Analysis Report: BioScrip, Inc. (NASDAQ:BIOS), Big Lots Inc. (NYSE:BIG) - Beacon Chronicle
06/15/16 07:39 AMBioScrip Inc. (BIOS) Drops 19.43% on June 13 - Equities.com
06/14/16 02:48 PMStock Alert: BioScrip, Inc. (NASDAQ:BIOS), Liberty Sirius XM Group (NASDAQ:LSXMA), Monster Beverage Corporation ... - KC Register
06/14/16 02:48 PMCitigroup Inc. (NYSE:C) Went Down-1.69%: BioScrip, Inc. (NASDAQ:BIOS), Prosperity Bancshares Inc. (NYSE:PB ... - KC Register
About BioScrip

BioScrip logoBioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates through approximately 70 service locations in over 30 states. The Company offers home infusion services to provide clinical management services and the delivery of prescription medications. The Company provides services in coordination with, and under the direction of, the patient's physician. The Company's multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to the patient's specific needs. Its platform provides service capabilities to deliver clinical management services that offer patients a community-based and home-based care environment.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: BIOS
  • CUSIP: 09069N10
Key Metrics:
  • Previous Close: $2.55
  • 50 Day Moving Average: $2.595
  • 200 Day Moving Average: $2.168
  • P/E Ratio: N/A
  • P/E Growth: -1.010
  • Market Cap: $179.86M
  • Current Quarter EPS Consensus Estimate: $-0.200 EPS
Additional Links:
BioScrip (NASDAQ:BIOS) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha